0001104659-23-071755.txt : 20230615 0001104659-23-071755.hdr.sgml : 20230615 20230615200008 ACCESSION NUMBER: 0001104659-23-071755 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Potts Jeannette CENTRAL INDEX KEY: 0001814693 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36294 FILM NUMBER: 231019074 MAIL ADDRESS: STREET 1: C/O FORMA THERAPEUTICS HOLDINGS, INC. STREET 2: 500 ARSENAL STREET, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: uniQure N.V. CENTRAL INDEX KEY: 0001590560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP BUSINESS PHONE: 1-339-970-7000 MAIL ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP FORMER COMPANY: FORMER CONFORMED NAME: uniQure B.V. DATE OF NAME CHANGE: 20131030 3 1 tm2318865-2_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2023-06-13 1 0001590560 uniQure N.V. QURE 0001814693 Potts Jeannette C/O UNIQURE N.V. PAASHEUVELWEG 25A AMSTERDAM P7 1105BP NETHERLANDS 0 1 0 0 See Remarks Officer Title: Chief Legal and Compliance Officer. Exhibit List: Exhibit 24 - Power of Attorney /s/ Christian Klemt, Attorney-in-Fact 2023-06-15 EX-24 2 tm2318865d2_ex-24.htm EXHIBIT 24

 

Exhibit 24

 

POWER OF ATTORNEY

 

I hereby constitute and appoints each of Matthew Kapusta and Christian Klemt, signing singly, my true and lawful attorney-in-fact to:

 

(1)           execute on my behalf any Form 3-Initial Statement of Beneficial Ownership of Securities, Form 4-Statement of Changes of Beneficial Ownership of Securities, or Form 5-Annual Statement of Beneficial Ownership of Securities, including any amendments, supplements or exhibits thereto (each, a “Section 16 Report”), which I am required to file in my capacity as an officer, director or owner of greater than 10% of the outstanding shares of uniQure N.V. (the “Company”) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Act”) and the rules thereunder;

 

(2)           do and perform any and all acts for and on my behalf that may be necessary or desirable to complete and execute any Section 16 Report and timely file such report with the United States Securities and Exchange Commission and any stock exchange or similar authority;

 

(3)           seek or obtain, as my representative and on my behalf, information on transactions in the Company’s securities from any third party, including brokers, employee benefit plan administrators and trustees, and I hereby authorize any such third party to release any such information to each of my attorneys-in-fact appointed by this Power of Attorney; and

 

(4)           take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be to my benefit, in my best interest, or that I am legally required to do, it being understood that the documents executed by such attorney-in-fact on my behalf pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

I hereby grant to each attorney-in-fact hereunder full power and authority to do and perform any and every act and thing whatsoever necessary or desirable to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as I might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.

 

I acknowledge that this Power of Attorney does not relieve me of my responsibilities to comply with Section 16 of the Act and the attorneys-in-fact, in serving in such capacity at my request, are not assuming, nor is the Company assuming, any of my responsibilities to comply with Section 16 of the Act.

 

This Power of Attorney shall remain in full force and effect until I am no longer required to file Section 16 Reports with respect to my holdings of and transactions in Company securities, unless I earlier revoke it in a signed writing delivered to one or more attorneys-in-fact.

 

IN WITNESS WHEREOF, I have caused this Power of Attorney to be executed as of this 15th day of June, 2023.

 

By:  /s/ Jeannette Potts  
Print Name: Jeannette Potts